HeyPatient is now an official Innosuisse scale-up

Winterthur – The Swiss innovation agency Innosuisse classifies heyPatient AG as a start-up with particularly high growth potential. Accordingly, the Winterthur-based company receives the Innosuisse Scale-up Program Award and is accepted into the second phase of the Scale-up Program.

(CONNECT) According to a press release, heyPatient AG has successfully qualified for the second, i.e. scale-up phase of the Innosuisse coaching program and is therefore now an official Innosuisse scale-up. This gives the healthtech company, which was founded in 2019, access to intensive coaching on scaling, organization, international compliance, IPO strategy, legal and financing.

For heyPatient, inclusion in this program means confirmation of the business model and its technological basis, recognition of the market development to date and confidence in the growth potential: "This confirmation motivates us to consistently continue on our path, to sustainably improve the digital patient journey and to support healthcare organizations in making their processes more efficient and patient-centric," CEO Matthias Spühler is quoted as saying.

HeyPatient offers a digital platform for communication between medical facilities on the one hand and patients on the other. As the Winterthur-based company explains, its current focus is "clearly on further scaling". This includes the further expansion of efficient and scalable processes, the further development of the organizational structure, the further expansion of the partner network and preparations for international expansion. ce/mm

View full article